A deep dive into ferritin nanoparticle advancements: experimental and computational perspectives

Area of Science:

• Nanotechnology and Biomedicine
• Biomaterials Science
• Computational Biology

Background:

• Ferritin, a natural iron-storage protein, possesses a biocompatible 12 nm nanocage structure.
• Its intrinsic targeting via transferrin receptor 1 (TfR1) and adaptability make it a versatile platform.
• Ferritin nanoparticles are explored for drug delivery, gene therapy, diagnostics, and therapeutic applications.

Purpose of the Study:

• To review recent experimental and computational advances in ferritin-based nanoparticles.
• To highlight ferritin's applications in diverse biomedical fields.
• To discuss challenges and future directions for ferritin nanotechnology.

Main Methods:

• Experimental approaches: pH-responsive disassembly, passive diffusion, engineered self-assembly for high-capacity loading (e.g., doxorubicin, siRNA, CRISPR-Cas9).
• Computational methods: Molecular dynamics simulations, density functional theory, machine learning classifiers, bioinformatics tools (WGCNA, PPI networks).
• Design strategies: Docking-guided designs for enhanced vaccine epitope exposure and PROTAC efficiency.

Main Results:

• Ferritin nanocages demonstrate high therapeutic loading capacity and precise tumor targeting via TfR1.
• Computational studies predict stable interfaces, elucidate catalytic mechanisms, and identify biomarkers.
• Bioinformatics tools reveal ferritinophagy roles in diseases, aiding precision diagnostics and nanocarrier optimization.

Conclusions:

• Ferritin nanoparticles show significant promise in nanomedicine for targeted drug delivery, gene therapy, and diagnostics.
• Overcoming challenges in scalability, immunogenicity, and regulatory validation is crucial for clinical translation.
• Future directions include AI-assisted design, personalized therapies, and sustainable nanotechnology development.